Not Signed In -
Hormone Therapy |
Hormone Therapy/ht; Ht |
HT or Ht may stand for: Haiti (ISO 3166-1 alpha-2 country code, HT) Hot Topic -- retail store Haitian Creole language (ISO 639 alpha-2, ht) Hanshin Tigers, abbreviated HT height (ht.) Hankook Tire Hersha Hospitality Trust -- stock symbol HyperTransport -- computer bus Hyper-threading -- microprocessors Hypertensive -- medical condition wherein blood pressure is chronically elevated Heim theory -- physics Handie-Talkie -- amateur radio Harris Teeter -- grocery store Hrvatski Telekom -- Croat ...
Wikipedia - [full article]
Hormone Therapy Clinical Trials
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
adenocarcinoma of the prostate
- Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00005769 - Active, not recruiting
Menopause
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00104715 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003645 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer
- Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00027859 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003437 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia
- Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00003771 - Active, not recruiting
menopausal symptoms; stage I breast cancer; stage II breast cancer; breast cancer in situ
- High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
ClinicalTrials.gov Identifier: NCT00131924 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00288080 - Recruiting
Prostate Cancer
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006044 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer; bone metastases
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
ClinicalTrials.gov Identifier: NCT00082810 - Active, not recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00055731 - Recruiting
stage III prostate cancer; stage II prostate cancer
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003290 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer
- Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003323 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life; sexual dysfunction and infertility
- Combination Chemotherapy in Treating Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
stage I breast cancer
- Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
ClinicalTrials.gov Identifier: NCT00066690 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
refractory plasma cell neoplasm
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
ClinicalTrials.gov Identifier: NCT00411853 - Recruiting
Hormone Refractory Prostate Cancer
- Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
ClinicalTrials.gov Identifier: NCT00004125 - Active, not recruiting
Breast Cancer
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Hormone Therapy in Treating Men With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002651 - Recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Letrozole With or Without Tipifarnib in Treating Women With Locally Advanced, Locally Recurrent, or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00060177 - Active, not recruiting
Breast Cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
breast cancer in situ; intraductal breast carcinoma
- Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
ClinicalTrials.gov Identifier: NCT00114270 - Active, not recruiting
Breast Cancer; Osteoporosis
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003278 - Active, not recruiting
primary central nervous system lymphoma; intraocular lymphoma
- Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00053898 - Active, not recruiting
breast cancer in situ; intraductal breast carcinoma
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Combination Chemotherapy in Treating Women With Resected Breast Cancer
ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00382070 - Recruiting
Breast Cancer
- Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
ClinicalTrials.gov Identifier: NCT00407251 - Recruiting
Hormone Refractory Prostate Cancer
- IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
ClinicalTrials.gov Identifier: NCT00077168 - Active, not recruiting
intraductal breast carcinoma; breast cancer in situ
- Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00080743 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Anastrozole With or Without Trastuzumab in Treating Postmenopausal Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00022672 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Treating Women With Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00005983 - Active, not recruiting
stage II breast cancer
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00002720 - Active, not recruiting
stage I breast cancer
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
ClinicalTrials.gov Identifier: NCT00046826 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
ClinicalTrials.gov Identifier: NCT00064025 - Recruiting
Endometrial Cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00021450 - Recruiting
stage II prostate cancer
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00090844 - Active, not recruiting
Drug Toxicity; hormonal changes; stage I breast cancer; stage II breast cancer
- Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003449 - Active, not recruiting
recurrent ovarian epithelial cancer
- Growth and Metabolic Response to Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment Versus Growth Hormone Alone in Boys Born SGA.
ClinicalTrials.gov Identifier: NCT00522743 - Active, not recruiting
SGA and Growth
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00002528 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00057941 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Women With Hormone Receptor-Positive Breast Cancer That Can be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00194792 - Recruiting
Breast Cancer
- Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00032136 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
ClinicalTrials.gov Identifier: NCT00580775 - Enrolling by invitation
Menopausal Women
- Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00553410 - Recruiting
Breast Cancer
- Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00009997 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
- Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
ClinicalTrials.gov Identifier: NCT00136032 - Active, not recruiting
Growth Hormone Deficiency; Pituitary Tumor; Pituitary Disease
- Exemestane and Raloxifene in Treating Postmenopausal Women With a History of Ductal Carcinoma in Situ, Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00004247 - Active, not recruiting
Breast Cancer; breast cancer in situ
- Chemotherapy Plus Surgery in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00003013 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
ClinicalTrials.gov Identifier: NCT00080756 - Recruiting
Breast Cancer
- Tamoxifen in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00003678 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00002582 - Active, not recruiting
stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
- Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
ClinicalTrials.gov Identifier: NCT00185458 - Active, not recruiting
Menopause
- Clodronate With or Without Chemotherapy and/or Tamoxifen in Treating Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00009945 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00107263 - Active, not recruiting
Osteoporosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
ClinicalTrials.gov Identifier: NCT00002679 - Active, not recruiting
Male Breast Cancer; stage II breast cancer; stage IIIA breast cancer
- Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
ClinicalTrials.gov Identifier: NCT00066469 - Recruiting
post-transplant lymphoproliferative disorder
- Docetaxel, Bevacizumab, Thalidomide, and Prednisone in Treating Patients With Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00091364 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
ClinicalTrials.gov Identifier: NCT00126464 - Active, not recruiting
intraductal breast carcinoma; breast cancer in situ
- Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
ClinicalTrials.gov Identifier: NCT00066586 - Active, not recruiting
Breast Cancer
Resources
- Hormone Therapy (National Women's Health Information Center)
email this page
print this page
bookmark this page
feedback on this page
